Oncology Institute (NASDAQ:TOI) Posts Quarterly Earnings Results

Oncology Institute (NASDAQ:TOI) issued its earnings results on Monday. The company reported ($0.14) EPS for the quarter, Zacks reports. Oncology Institute had a negative return on equity of 186.83% and a negative net margin of 17.63%. Oncology Institute updated its FY 2025 guidance to EPS.

Oncology Institute Stock Performance

Shares of NASDAQ:TOI opened at $1.00 on Monday. The company has a current ratio of 2.49, a quick ratio of 2.27 and a debt-to-equity ratio of 5.91. The company has a market cap of $75.27 million, a price-to-earnings ratio of -1.28 and a beta of 0.41. Oncology Institute has a 12 month low of $0.13 and a 12 month high of $1.89. The company has a 50-day moving average price of $0.78 and a 200-day moving average price of $0.45.

Oncology Institute Company Profile

The Oncology Institute, Inc, an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services.